Intracellular aggregation of human stefin B: Confocal and electron microscopy study

Biology of the Cell

Volumn 102, Issue 6, 2010, Pages 319-334

  Čeru, Slavko ^a   Layfield, Robert ^b   Zavašnik Bergant, Tina ^a   Repnik, Urška ^a   Kopitar Jerala, Nataša ^a   Turk, Vito ^a   Žerovnik, Eva ^a  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Aggresome; Amyloid; Autophagy; Progressive myoclonus epilepsy of type 1 (EPM1) mutant; Protein aggregation; Stefin B

Indexed keywords

FLUORESCENT DYE; LC3 PROTEIN; PROGRESSIVE MYOCLONUS EPILEPSY OF TYPE 1; PROTEASOME; PROTEIN; PROTEIN ADAPTOR P62; STEFIN B; UBIQUITIN; UNCLASSIFIED DRUG; CSTB PROTEIN, HUMAN; CYSTATIN B;

AGGRESOME; ANIMAL CELL; ARTICLE; AUTOPHAGY; CELL NUCLEUS; CELL SURVIVAL; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; CYTOSOL; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNOGOLD LABELING; IN VITRO STUDY; IN VIVO STUDY; MICROFILAMENT; MICROTUBULE; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY; WILD TYPE; CELL SEPARATION; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE; ULTRASTRUCTURE; WESTERN BLOTTING;

MAMMALIA;

AUTOPHAGY; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SEPARATION; CELL SURVIVAL; CYSTATIN B; CYTOPLASM; FLOW CYTOMETRY; HUMANS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; PROTEASOME ENDOPEPTIDASE COMPLEX; TRANSFECTION;

EID: 77953383317     PISSN: 02484900     EISSN: 1768322X     Source Type: Journal    
DOI: 10.1042/BC20090163     Document Type: Article

References (67)

1. Abrahamson, M., Barret, A.J., Salvesen, G. and Grubb, A. (1986) Isolation of six cysteine proteinase inhibitors from human urine. J. Biol. Chem. 261, 11282-11289
2. Alakurtti, K., Weber, E., Rinne, R., Theol, G., Haan, G., Lindhout, D., Salmikangas, P., Saukko, P., Lahtinen, U. and Lehesjoki, A.E. (2005) Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy, EPM1, mutations. Eur. J. Hum. Genet. 13, 208-215
3. Anderluh, G., Gutierrez-Aguirre, I., Rabzelj, S., Čeru, S., Kopitar-Jerala, N., Maček, P., Turk, V. and Žerovnik, E. (2005) Interaction of human stefin B in the prefibrillar oligomeric form with membranes - correlation with cellular toxicity. FEBS J. 272, 3042-3051
4. Beaudoin, S., Goggin, K., Bissonnette, C., Grenier, C. and Roucou, X. (2008) Aggresomes do not represent a general cellular response to protein misfolding in mammalian cells. BMC Cell Biol. 9, 59
5. Bence, N.F., Sampat, R.M. and Kopito, R.R. (2001) Impairment of the ubiquitin - proteasome system by protein aggregation. Science 292, 1552-1555
6. Bjorkoy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Overvatn, A., Stenmark, H. and Johansen, T. (2005) p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on Huntingtin-induced cell death. J. Cell Biol. 171, 603-614 (Pubitemid 41668720)
7. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein - dye binding. Anal. Biochem. 72, 248-254
8. Broadley, S.A. and Hartl, F.U. (2009) The role of molecular chaperones in human misfolding diseases. FEBS Lett. 583, 2647-2653
9. Bückig, A., Tikkanen, R., Herzog, V. and Schmitz, A. (2002) Cytosolic and nuclear aggregation of the amyloid beta-peptide following its expression in the endoplasmic reticulum. Histochem. Cell Biol. 118, 353-360
10. Cipollini, E., Riccio, M., Di Giaimo, R., Dal Piaz, F., Pulice, G., Catania, S., Caldarelli, I., Dembic, M., Santi, S. and Melli, M. (2008) Cystatin B and its EPM1 mutants are polymeric and aggregate prone in vivo. Biochim. Biophys. Acta 1783, 312-322
11. Cirman, T., Oresić, K., Mazovec, G.D., Turk, V., Reed, J.C., Myers, R.M., Salvesen, G.S. and Turk, B. (2004) Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J. Biol. Chem. 279, 3578-3587
12. Cuervo, A.M. (2004) Autophagy: many paths to the same end. Mol. Cell. Biochem. 263, 55-72
13. Čeru, S. and Žerovnik, E. (2008) Similar toxicity of the oligomeric molten globule state and the prefibrillar oligomers. FEBS Lett. 582, 203-209
14. Čeru, S., Rabzelj, S., Kopitar-Jerala, N., Turk, V. and Žerovnik, E. (2005) Protein aggregation as a possible cause for pathology in a subset of familial Unverricht - Lundborg disease. Med. Hypotheses 64, 955-959
15. Čeru, S., Jenko Kokalj, S., Rabzelj, S., Škarabot, M., Gutierrez-Aguirre, I., Kopitar-Jerala, N., Anderluh, G., Turk, D., Turk, V. and Žerovnik, E. (2008) Size limits for toxic oligomers of amyloidogenic proteins: a case study of human stefin B (cystatin B). Amyloid 15, 147-159
16. D'Amato, E., Kokaia, Z., Nanobashvili, A., Reeben, M., Lehesjoki, A.E., Saarma, M. and Lindvall, O. (2000) Seizures induce widespread upregulation of cystatin B, the gene mutated in progressive myoclonus epilepsy, in rat forebrain neurons. Eur. J. Neurosci. 12, 1687-1695
17. Di Giamo, R., Riccio, M., Santi, S., Galeotti, C., Ambrosetti, D.C. and Melli, M. (2002) New insights into the molecular basis of progressive myoclonus epilepsy: a multiprotein complex with cystatin B. Hum. Mol. Genet. 11, 2941-2950
18. Du, Y., Yang, D., Li, L., Luo, G., Li, T., Fan, X., Wang, Q., Zhang, X., Wang, Y. and Le, W. (2009) An insight into the mechanistic role of p53-mediated autophagy induction in response to proteasomal inhibition-induced neurotoxicity. Autophagy 5, 663-675
19. Edwards, M.J.J., Hargreaves, I.P., Heales, S.J.R., Jones, S.J., Ramachandran, V., Bhatia, K.P. and Sisodiya, S. (2002) N-acetylcysteine and Unverricht - Lundborg disease variable response and possible side effects. Neurology 59, 1447-1449 (Pubitemid 35286007)
20. Fortun, J., Dunn, Jr, W.A., Joy, S., Li, J. and Notterpek, L. (2003) Emerging role for autophagy in the removal of aggresomes in Schwann cells. J. Neurosci. 23, 10672-10680 (Pubitemid 37485281)
21. Garcia-Mata, R., Gao, Y.S. and Sztul, E. (2002) Hassles with taking out the garbage: aggravating aggresomes. Traffic 3, 388-396 (Pubitemid 34746406)
22. Goldberg, A.L. (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426, 895-899
23. Gunawardena, S., Her, L.S., Brusch, R.G., Laymon, R.A., Niesman, I.R., Gordesky-Gold, B., Sintasath, L., Bonini, N.M. and Goldstein, L.S. (2003) Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 40, 25-40
24. Houseweart, M.K., Pennacchio, L.A., Vilaythong, A., Peters, C., Noebels, J.L. and Myers, R.M. (2003) Cathepsin B but not cathepsins L or S contributes to the pathogenesis of Unverricht - Lundborg progressive myoclonus epilepsy (EPM1). J. Neurobiol. 56, 315-327
25. Irvine, G.B., El-Agnaf, O.M., Shankar, G.M. and Walsh, D.M. (2008) Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases. Mol. Med. 14, 451-464
26. Jenko, S., Škarabot, M., Kenig, M., Guncar, G., Muševic, I., Turk, D. and Žerovnik, E. (2004) Different propensity to form amyloid fibrils by two homologous proteins - human stefins A and B: searching for an explanation. Proteins 55, 417-425
27. Jenko-Kokalj, S., Guncar, G., Štern, I., Morgan, G., Rabzelj, S., Kenig, M., Staniforth, R.A., Waltho, J.P., Žerovnik, E. and Turk, D. (2007) Essential role of proline isomerization in stefin B tetramer formation. J. Mol. Biol 366, 1569-1579
28. Jerala, R. and Žerovnik, E. (1999) Accessing the global minimum conformation of stefin A dimer by annealing under partially denaturing conditions. J. Mol. Biol. 291, 1079-1089
29. Jerala, R., Trstenjak, M., Lenarcic, B. and Turk, V. (1988) Cloning a synthetic gene for human stefin B and its expression in E.coli. FEBS Lett. 239, 41-44
30. Joensuu, T., Kuronen, M., Alakurtti, K., Tegelberg, S., Hakala, P., Aalto, A., Huopaniemi, L., Aula, N., Michellucci, R., Eriksson, K. and Lehesjoki, A.E. (2007) Cystatin B: mutation detection, alternative splicing and expression in progressive myclonus epilepsy of Unverricht - Lundborg type (EPM1) patients. Eur. J. Hum. Genet. 15, 185-193
31. Joensuu, T., Lehesjoki, A.E. and Kopra, O. (2008) Molecular background of EPM1-Unverricht - Lundborg disease. Epilepsia 49, 557-563
32. Johnston, J.A., Ward, C.L. and Kopito, R.R. (1998) Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143, 1883-1898
33. Kaasik, A., Kuum, M., Aonurm, A., Kalda, A., Vaarmann, A. and Zharkovsky, A. (2007) Seizures, ataxia, and neuronal loss in cystatin B heterozygous mice. Epilepsia 48, 752-757
34. Kagan, B.L., Hirakura, Y., Azimov, R., Azimova, R. and Lin, M.C. (2002) The channel hypothesis of Alzheimer's disease: current status. Peptides 23, 1311-1315
35. Kaganovich, D., Kopito, R.R. and Frydman, J. (2008) Misfolded proteins partition between two distinct quality control compartments. Nature 454, 1088-1095
36. Kawahara, M., Kuroda, Y., Arispe, N. and Rojas, E. (2000) Alzheimer's beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J. Biol. Chem. 275, 14077-14083
37. Kayed, R., Sokolov, Y., Edmonds, B., McIntire, T.M., Milton, S.C., Hall, J.E. and Glabe, C.G. (2004) Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279, 46363-46366
38. Kolodziejska, K.E., Burns, A.R., Moore, R.H., Stenoien, D.L. and Eissa, N.T. (2005) Regulation of inducible nitric oxide synthase by aggresome formation. Proc. Natl. Acad. Sci. U.S.A. 102, 4854-4859
39. Kopitar, M., Brzin, J., Zvonar, T., Locnikar, P., Kregar, I. and Turk, V. (1978) Inhibition studies of an intracellular inhibitor on thiol proteinases. FEBS Lett. 91, 355-359
40. Kopitar-Jerala, N., Curin-Serbec, V., Jerala, R., Krizaj, I., Gubensek, F. and Turk, V. (1993) Monoclonal antibodies to human stefin B and determination of their epitopes. Biochim. Biophys. Acta 1164, 75-80
41. Kopito, R.R. (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10, 524-530
42. Lalioti, M.D., Scott, H.S., Buresi, C., Rossier, C., Bottani, A., Morris, M.A., Malafosse, A. and Antonarakis, S.E. (1997) Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy, Nature 386, 847-851
43. Layfield, R., Lowe, J. and Bedford, L. (2005) The ubiquitin - proteasome system and neurodegenerative disorders. Essays Biochem. 41, 157-171
44. Lefebvre, C., Cocquerelle, C., Vandenbulcke, F., Hot, D., Huot, L., Lemoine, Y. and Salzet, M. (2004) Transcriptomic analysis in the leech Theromyzon tessulatum: involvement of cystatin B in innate immunity. Biochem. J. 380, 617-625 (Pubitemid 38850502)
45. Lehtinen, M.K., Tegelberg, S., Schipper, H., Su, H., Zukor, H., Manninen, O., Kopra, O., Joensuu, T., Hakala, P., Bonni, A. and Lehesjoki, A.E. (2009) Cystatin B deficiency sensitizes neurons to oxidative stress in progressive myoclonus epilepsy, EPM1. J. Neurosci. 29, 5910-5915
46. Malaspina, A., Kaushik, N. and de Belleroche, J. (2001) Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J. Neurochem. 77, 132-145 (Pubitemid 32245087)
47. Marx, F.P., Holzmann, C., Strauss, K.M., Li, L., Eberhardt, O., Gerhardt, E., Cookson, M.R., Hernandez, D., Farrer, M.J., Kachergus, J. et al. (2003) Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease, Hum. Mol. Genet. 12, 1223-1231
48. Matsunaga, Y., Žerovnik, E., Yamada, T. and Turk, V. (2002) Conformational changes preceding amyloid-fibril formation of amyloid-beta and stefin B; parallels in pH dependence. Curr. Med. Chem. 9, 1717-1724
49. Nedelsky, N.B., Todd, P.K. and Taylor, J.P. (2008) Autophagy and the ubiquitin - proteasome system: collaborators in neuroprotection. Biochim. Biophys. Acta 1782, 691-699
50. Olanow, C.W., Perl, D.P., DeMartino, G.N. and McNaught, K.S. (2004) Lewy-body formation is an aggresome-related process: a hypothesis. Lancet Neurol. 3, 496-503
51. Pandey, U.B., Nie, Z., Batlevi, Y., McCray, B.A., Ritson, G.P., Nedelsky, N.B., Schwartz, S.L., DiProspero, N.A., Knight, M.A., Schuldiner, O. et al. (2007) HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447, 859-863
52. Pennacchio, L.A., Lehesjoki, A.E., Stone, N.E., Willour, V.L., Virtaneva, K., Maio, J., D'Amato, E., Ramirez, L., Faham, M., Koskiniemi, M. et al. (1996) Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271, 1731-1734 (Pubitemid 26102822)
53. Pennacchio, L.A., Bouley, D.M., Higgins, K.M., Scott, M.P., Noebels, J.L. and Myers, R.M. (1998) Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat. Genet. 20, 251-258
54. Rabzelj, S., Turk, V. and Žerovnik, E. (2005) In vitro study of stability and amyloid-fibril formation of two mutants of human stefin B (cystatin B) occurring in patients with EPM1. Protein Sci. 14, 2713-2722
55. Rabzelj, S., Viero, G., Gutiérrez-Aguirre, I., Turk, V., Dalla Serra, M., Anderluh, G. and Žerovnik, E. (2008) Interaction with model membranes and pore formation by human stefin B: studying the native and prefibrillar states. FEBS J. 275, 2455-2466 (Pubitemid 351600082)
56. Riccio, M., Di Giaimo, R., Pianetti, S., Palmieri, P.P., Melli, M. and Santi, S. (2001) Nuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1). Exp. Cell Res. 262, 84-94 (Pubitemid 32980247)
57. Shvets, E., Fass, E., Scherz-Shouval, R. and Elazar, Z. (2008) The N-terminus and Phe52 residue of LC3 recruit p62/SQSTM1 into autophagosomes. J. Cell Sci. 121, 2685-2695
58. Staniforth, R.A., Giannini, S., Higgins, L.D., Conroy, M.J., Hounslow, A.M., Jerala, R., Craven, C.J. and Waltho, J.P. (2001) Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily. EMBO J. 20, 4774-4781 (Pubitemid 32848630)
59. Stefani, M. and Dobson, C.M. (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 81, 678-699
60. Stubbs, M.T., Laber, B., Bode, W., Huber, R., Jerala, R., Lenarcic, B. and Turk, V. (1990) The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel typeof proteinase inhibitor interaction. EMBO J. 9, 1939-1947
61. Turk, V., Stoka, V. and Turk, D. (2008) Cystatins: biochemical and structural properties, and medical relevance. Front. Biosci. 13, 5406-5420
62. Tokuyasu, K.T. (1978) A study of positive staining of ultrathin frozen sections. J. Ultrastruct. Res. 63, 287-307
63. Verdot, L., Lalmanach, G., Vercruysse, V., Hartmann, S., Lucius, R., Hoebeke, J., Gauthier, F. and Vray, B. (1996) Cystatins up-regulate nitric oxide release from interferon-gamma-activated mouse peritoneal macrophages. J. Biol. Chem. 271, 28077-28081
64. Walsh, D.M. and Selkoe, D.J. (2004) Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Pept. Lett. 11, 213-228
65. Zapata-Hommer, O. and Griesbeck, O. (2003) Efficiently folding and circularly permuted variants of the Sapphire mutant of GFP. BMC Biotechnol. 22, 3-5
66. Žerovnik, E., Pompe-Novak, M., Škarabot, M., Ravnikar, M., Musevic, I. and Turk, V. (2002a) Human stefin B readily forms amyloid fibrils in vitro. Biochim. Biophys. Acta 1594, 1-5
67. Žerovnik, E., Zavašnik-Bergant, V., Kopitar-Jerala, N., Pompe-Novak, M., Škarabot, M., Goldie, K., Ravnikar, M., Muševic, I. and Turk, V. (2002b) Amyloid fibril formation by human stefin B in vitro: immunogold labelling and comparison to stefin A. Biol. Chem. 383, 859-863